Elevated exo-circPDE8A derived from pancreatic ductal adenocarcinoma (PDAC), promotes lymphatic invasion via stimulating MET by miR-338/MACC1/MET pathway [93]. Here, MET is linked to pancreatic ductal adenocarcinoma.